enteroviru
first
isol
fecal
throat
swab
sampl
patient
central
nervou
system
complic
california
sinc
link
outbreak
foot
hand
mouth
diseas
hfmd
often
selflimit
infect
character
sever
form
character
acut
flaccid
paralysi
brainstem
encephalomyel
coxsackieviru
also
play
major
role
hand
foot
mouth
diseas
hfmd
epidem
renal
failur
also
report
two
hfmd
case
due
infect
recent
one
case
acut
kidney
injuri
secondari
infect
report
xu
colleagu
hfmd
outbreak
report
differ
part
asia
pacif
often
neurolog
complic
children
age
five
especi
preschool
center
observ
singapor
exampl
million
probabl
case
hfmd
fatal
case
report
mainland
china
alon
high
econom
cost
year
case
encephalitisneurolog
complic
result
viru
infect
report
colorado
unit
state
america
yearli
cyclic
pattern
hand
foot
mouth
diseas
outbreak
report
asia
pacif
region
driver
season
npev
usa
studi
recent
ponssalort
cowork
identifi
month
juli
septemb
peak
infect
outbreak
alway
result
overburden
health
care
system
pain
loss
live
sever
case
diseas
even
though
recent
mathemat
model
find
use
data
singapor
show
high
incid
rate
limit
disabilityadjust
life
year
dali
compar
infecti
diseas
preval
south
east
asian
countri
hfmd
potenti
threat
global
health
analysi
sampl
earlier
collect
polioviru
surveil
studi
seven
western
african
countri
identifi
sever
npev
circul
region
echovirus
domin
strain
studi
also
identifi
least
describ
type
well
among
other
circul
region
identif
molecular
character
npev
west
africa
point
global
divers
virus
call
stronger
surveil
system
better
manag
control
recent
minor
outbreak
hfmd
attribut
coxsackievirus
even
though
magnitud
effect
outbreak
larg
need
understand
pathogenesi
infect
well
quantifi
burden
easi
diseas
monitor
coxsackieviru
isol
usa
recogn
one
caus
agent
hand
foot
mouth
diseas
differ
part
world
includ
usa
europ
finland
spain
asia
pacif
taiwan
japan
china
thailand
vietnam
among
countri
region
emerg
player
hfmd
outbreak
eventu
complic
vaccin
antivir
therapi
develop
hfmd
broadli
studi
howev
littl
success
achiev
vaccin
therapi
develop
thu
emerg
point
urgent
need
understand
infect
dynam
coxsackieviru
link
sporad
outbreak
atyp
hfmd
infect
china
franc
contribut
case
hfmd
correspondingli
china
time
becom
one
major
caus
agent
sever
mild
case
hand
foot
mouth
diseas
china
account
approxim
mild
sever
case
high
possibl
virul
strain
hfmd
virus
emerg
frequent
recombin
enterovirus
report
virus
potenti
caus
major
outbreak
potenti
threat
global
health
enteroviru
first
identifi
throat
swab
children
suffer
respiratori
infect
name
fermon
viru
schiebl
cowork
sinc
sever
outbreak
respiratori
infect
result
enteroviru
infect
report
taiwan
usa
canada
europ
among
endem
region
link
acut
flaccid
paralysi
acut
flaccid
myeliti
exacerb
infect
sever
research
studi
demonstr
infect
dynam
viral
infect
exampl
abil
infect
neuron
cell
report
brown
colleagu
use
neuron
cell
line
confirm
neurotrop
line
observ
acut
flaccid
myeliti
paralysi
patient
system
molecular
divers
studi
lyon
franc
show
diversif
pattern
viru
establish
experiment
mous
model
hixon
colleagu
studi
effect
provid
much
need
anim
model
better
understand
infect
cycl
viru
establish
human
host
cell
interact
provid
insight
pathogenesi
infect
eventu
vital
design
antivir
vaccin
viru
necess
extens
understand
molecular
mechan
virus
includ
infect
paradigm
key
develop
vaccin
antivir
therapi
well
player
molecular
epidemiolog
viral
tissu
tropism
depend
sole
cellular
receptor
respons
attach
entri
viru
particl
host
cell
human
host
protein
act
receptor
viral
attach
eventu
entri
cell
play
role
tissu
tropism
variou
viral
infect
sever
receptor
identifi
variou
picornavirus
polioviru
receptor
first
one
identifi
famili
recent
reemerg
enterovir
infect
outbreak
need
document
recent
find
entri
process
virus
point
eventu
gap
need
research
interplay
viral
protein
human
host
protein
play
major
role
attach
entri
intern
viral
infect
specif
virus
use
confin
set
receptor
cell
membran
entri
suscept
cell
eventu
uncoat
viru
process
vital
eventu
reproduct
viral
genom
continu
viral
life
cycl
among
picornavirus
polioviru
extens
studi
sever
studi
nonpolio
enterovirus
reli
studi
host
factor
identifi
possibl
receptor
npev
dynam
eventu
attach
entri
intern
yet
fulli
understood
clathrinmedi
endocytosi
entri
pathway
viru
identifi
sirna
screen
target
key
gene
involv
process
endocytosi
cytoskelet
dynam
endosom
traffick
sinc
alway
known
clathrin
mediat
endocytosi
major
rout
entri
suscept
cell
howev
inhibit
clathrinmedi
endocytosi
pathway
chlorpromazin
cpz
dynasor
dn
inhibit
entri
cell
thu
point
combin
pathway
involv
viral
entri
among
picornavirus
polioviru
rhinoviru
receptor
identifi
first
enteroviru
receptor
describ
greve
colleagu
identifi
intercellular
adhes
molecul
rhinoviru
receptor
describ
polioviru
receptor
mendelshon
colleagu
receptor
identifi
put
receptor
abl
fulli
explain
divers
natur
symptom
observ
hand
foot
mouth
diseas
case
receptor
includ
human
scaveng
receptor
class
b
member
known
function
attach
receptor
also
uncoat
receptor
infect
receptor
ubiquit
express
differ
part
bodi
includ
neuron
cell
transmembran
receptor
known
receptor
respons
transport
endoplasm
reticulum
lysosom
also
key
lysosom
mainten
also
identifi
attach
receptor
human
enteroviru
speci
coxsacki
viru
sever
cell
type
known
express
includ
neuron
thu
may
directli
link
neurolog
complic
associ
infect
even
though
valid
acid
neutral
condit
undergo
conform
chang
lead
open
lipid
transfer
channel
mediat
eject
hydrophob
pocket
virion
process
import
viral
uncoat
pselectin
glycoprotein
membran
protein
express
white
blood
cell
respons
inflamm
tether
roll
leukocyt
vascular
endotheli
also
describ
receptor
respons
viral
entri
blood
cell
high
avid
viru
compar
yet
associ
low
infect
effeci
due
inabl
induc
viral
uncoat
sialyat
glycan
also
elucid
play
role
infect
dld
intestin
cell
anoth
attach
receptor
heparan
sulfat
glycosaminoglycan
also
identifi
tan
colleagu
point
number
bind
option
avail
viru
recent
studi
tseligka
cowork
confirm
import
heparan
sulfat
infect
explain
wide
rang
symptom
associ
infect
mild
infect
neurolog
complic
case
yang
colleagu
identifi
interact
viral
protein
human
annexin
protein
therebi
enhanc
infect
cell
surfac
vimentin
also
describ
attach
receptor
point
presenc
array
receptor
respons
viral
entri
cell
use
glycoproteom
approach
su
colleagu
identifi
cell
surfac
nucleolin
aid
attach
entri
interact
viral
protein
cell
surfac
prohibitin
recent
identifi
first
possibl
host
factor
interact
viral
entri
neuron
cell
therebi
aid
neuropathi
associ
infect
fibronectin
high
molecular
weight
glycoprotein
join
list
wide
array
receptor
discov
recent
qiao
colleagu
studi
postul
may
bind
fibronectin
protein
structur
protein
recent
genomewid
rnai
screen
yueng
colleagu
identifi
human
tryptophanyltrna
sythetas
hwar
entri
factor
well
result
studi
propos
interest
view
hwar
anchor
membran
surfac
may
act
receptor
thu
need
studi
unravel
exact
mechan
action
protein
suggest
perlman
gallagh
commentari
review
find
yueng
group
support
need
evalu
mechan
three
known
entri
receptor
find
interact
need
effect
entri
viru
suscept
cell
possibl
mode
action
new
perspect
infect
extens
review
commentari
issu
perlman
gallagh
given
virus
depend
receptor
entri
cell
find
studi
key
understand
pathogenesi
virus
upon
valid
exact
mechan
action
first
report
link
interferon
gamma
induc
viral
entri
cell
continu
research
aim
document
array
receptor
picornavirus
provid
vital
inform
design
antivir
therapi
vaccin
complet
map
essenti
host
protein
act
function
receptor
provid
rich
nich
design
develop
vaccin
therapi
infect
associ
exist
receptor
abl
complet
explain
pathogenesi
hand
foot
mouth
diseas
human
exampl
seem
facilit
small
number
enterovir
entri
cell
shown
support
array
virus
point
need
concert
effort
identifi
establish
possibl
function
entri
receptor
recent
identifi
hwar
need
valid
determin
effici
support
entri
enterovirus
report
studi
much
need
done
go
forward
fulli
understand
pathogenesi
hand
foot
mouth
diseas
full
map
entri
receptor
factor
abl
design
antivir
therapi
abl
block
entri
pathway
virus
thu
limit
viral
infect
import
design
antivir
enterovirus
associ
hand
foot
mouth
diseas
sialic
acid
well
intercellular
adhes
molecul
icam
identifi
receptor
enteroviru
facilit
entri
suscept
cell
coxsackievirusadenoviru
receptor
car
protein
first
receptor
identifi
coxsacki
b
viru
subgroup
c
e
f
thereaft
receptor
coxsackieviru
coxsackieviru
variant
respons
acut
hemorrhag
conjunct
ahc
describ
identifi
uncoat
receptor
sialic
acid
attach
receptor
low
densiti
lipoprotein
receptor
ldlr
purifi
hofer
cowork
hela
cell
cultur
supernat
classifi
minor
rhinoviru
receptor
low
lipoprotein
receptor
also
identifi
receptor
human
rhinoviru
intercellular
adhes
also
observ
aid
infect
mous
cell
coxsackieviru
rhinoviru
therebi
act
receptor
anoth
host
factor
recent
shown
play
role
entri
coxsackieviru
serotyp
enteroviru
studi
also
show
play
major
role
entri
serotyp
enterovirus
interestingli
sequenc
analysi
virus
use
enterovir
structur
protein
show
cluster
togeth
phylogenet
tree
studi
anoth
enteroviru
rhinoviru
c
rvc
associ
sever
respiratori
diseas
wheez
asthma
children
limit
inabl
grow
cell
cultur
howev
recent
studi
identifi
human
clathrin
relat
famili
member
function
receptor
rvc
receptor
major
group
rhinovirus
b
describ
major
group
rhinoviru
b
rva
rvb
bind
intercellular
adhes
molecul
minor
group
bind
low
densiti
lipoprotein
effici
entri
cell
identif
receptor
enterovirus
enabl
us
understand
pathogen
epidemiolog
import
group
virus
attach
adsorpt
entri
virus
cell
key
initi
stage
establish
effici
viral
infect
need
understand
infectionm
rhinovirus
goal
develop
antivir
vaccin
toward
group
virus
echovirus
decay
acceler
factor
daf
known
regul
complement
system
within
cell
also
shown
receptor
number
echovirus
coxsacki
b
virus
known
npev
receptor
summar
tabl
clearli
dissect
human
host
cell
factorsnpev
interact
provid
rich
nich
interact
map
key
design
antivir
therapi
group
epidemiolog
import
understand
mechan
involv
viral
entri
well
host
cell
factor
act
receptor
provid
import
inform
develop
viral
entri
inhibitor
given
virus
use
array
host
factorsmechan
infect
host
cell
block
known
entri
inhibitor
complet
inhibit
viral
entri
cell
support
need
clearli
elucid
map
host
factor
involv
viral
attach
eventu
entri
interact
human
host
factor
viral
protein
eventu
entri
cell
play
key
role
viral
tissu
tropism
therefor
suggest
concert
effort
need
put
place
identifi
possibl
entri
mechan
virus
aim
develop
npev
entri
inhibitor
cell
therebi
limit
viral
infect
fruit
eventu
identifi
host
factor
need
npev
entri
cell
recent
technolog
advanc
essenti
high
throughput
genomewid
screen
aim
discoveri
interplay
human
host
factor
step
involv
viral
infect
techniqu
revolution
identif
human
host
factor
involv
viral
infect
much
success
far
cherri
panda
present
techniqu
sirna
genomewid
screen
detail
basic
step
involv
sever
studi
use
sirna
genomewid
screen
identifi
role
human
host
factor
enterovir
infect
wu
colleagu
perform
sirna
genomewid
screen
identifi
sever
human
host
factor
necessari
viru
infect
studi
identifi
suscept
host
factor
resist
host
factor
involv
infect
aurkb
respect
point
import
interact
viral
protein
human
host
cell
factor
small
sirna
screen
target
human
membran
traffick
gene
identifi
vasolincontain
protein
import
protein
essenti
pv
viral
replic
interact
coloc
well
polioviru
infect
cell
shown
target
endoplasm
reticulum
protein
therebi
leav
erad
protein
tether
within
er
lumen
specif
inhibit
synthesi
herp
vimp
translat
level
cleav
therebi
interf
erad
process
studi
propos
may
interf
er
membran
hijack
erad
compon
improv
replic
pharmacolog
inhibit
myristoyltransferas
result
decreas
myristoyl
viru
structur
protein
reduct
acyl
inhibit
myristoly
sirna
knockdown
use
myrist
acid
analogu
prevent
cleavag
well
reduct
viral
rna
synthesi
studi
bring
forth
new
mechan
myristoyl
picornavir
protein
cleavag
process
thu
provid
altern
target
possibl
antivir
virus
rna
virus
evolv
human
host
cell
devis
mechan
protect
hostil
environ
within
host
interact
result
protect
viral
rna
integr
effici
infect
eventu
establish
diseas
review
barr
fearn
common
belief
rna
virus
remodel
host
cell
intracellular
membran
form
doubl
membran
structur
replic
organel
act
replic
site
genom
howev
mechan
host
cell
remodel
fulli
explic
sequenti
event
lead
format
replic
organel
yet
fulli
identifi
need
elucid
role
human
host
factor
especi
lipid
transfer
protein
within
endoplasm
reticulum
postul
enterovirus
usurp
lipid
transfer
membran
aid
format
replic
organel
stoeck
colleagu
show
hepat
c
viru
hcv
posit
strand
rna
viru
usurp
lipid
transfer
protein
neimann
pick
type
within
late
endosom
lead
local
cholesterol
lead
format
doubl
membran
structur
essenti
format
replic
organel
import
elucid
role
known
lipid
transport
protein
includ
steroidogen
acut
regulatori
protein
star
oxysterolbind
proteinrel
protein
b
format
replic
organel
npev
viral
infect
hsu
colleagu
show
virus
usurp
host
process
protein
reorgan
host
membran
form
replic
organel
via
reorgan
secretori
pathway
studi
show
enterovirus
flavivirus
exploit
host
machineri
result
recruit
lipid
augment
organel
vital
replic
specif
studi
show
enteroviru
rna
polymeras
bind
thu
illustr
import
phosphoinositid
lipid
viral
genom
replic
zhang
colleagu
elucid
vesicular
protein
coloc
lead
accumul
thu
point
essenti
role
hcv
viru
infect
far
shown
enterovirus
recruit
via
viral
protein
effici
viral
genom
replic
studi
dorobantu
colleagu
highlight
recruit
replic
organel
depend
interact
acyl
coenzym
acylcoa
bind
protein
domain
coxsackieviru
replic
thu
mechan
recruit
lead
subsequ
format
replic
complex
remain
unclear
furthermor
studi
xiao
cowork
show
protein
facilit
interact
replic
site
contrari
previou
studi
show
recruit
independ
rhinoviru
infect
particular
studi
point
select
recruit
strategi
facilit
protein
replic
site
infect
studi
banerje
recent
identifi
picornavir
protein
play
crucial
role
master
regul
hijack
host
cell
phospholipid
biosynthet
pathway
eventu
result
prolifer
membran
specif
point
studi
demonstr
viral
protein
alon
suffici
induc
phosphatidylcholin
pc
synthesi
picornavir
infect
end
need
illustr
mechan
use
viral
protein
recruit
array
cell
membran
biogenesi
lipid
find
whether
format
replic
organel
conserv
among
enterovirus
melia
colleagu
studi
architectur
replic
organel
form
encephalomyocard
viru
picornaviru
genu
cardioviru
studi
postul
endoplasm
reticulum
might
like
donor
organel
format
replic
organel
emcv
infect
common
belief
enterovirus
replic
evas
innat
immun
system
signal
aid
format
membran
web
recent
challeng
melia
colleagu
use
known
inhibitor
identifi
earlier
screen
van
der
schaar
colleagu
studi
show
mutant
coxsackieviru
abl
replic
within
golgi
apparatu
absenc
replic
organel
end
clear
step
involv
format
doubl
membran
structur
requir
format
enterovirus
replic
organel
remain
unresolv
need
dissect
exact
mechan
involv
format
replic
complex
mechan
without
replic
viral
genom
becom
compromis
might
open
toward
develop
design
antivir
target
exact
mechan
exampl
mechan
cell
remodel
rna
viru
infect
mine
recent
studi
nguyen
cowork
studi
identifi
fatti
acid
synthas
ceramidas
potenti
inhibitori
target
rhinovirus
highlight
possibl
target
lipid
transfer
replic
organel
format
possibl
therapeut
translat
viral
protein
upon
releas
cytoplasm
capindepend
thu
human
host
protein
bind
viral
type
intern
ribosom
entri
site
ire
effici
replic
nuclear
factor
reloc
cytoplasm
enterovir
infect
bind
intern
ribosom
entri
site
ire
act
intern
ribosom
entri
site
transact
factor
itaf
therebi
recruit
ribosom
site
protein
translat
rna
bind
protein
heterogen
nuclear
ribonucleoprotein
hnrnp
known
shuttl
nucleu
cytoplasm
enterovir
infect
lin
colleagu
demonstr
rna
bind
protein
rbp
itaf
bind
utr
sindbi
viru
viral
infect
thu
enhanc
viral
protein
translat
tolbert
cowork
demonstr
hnrnp
bind
specif
stem
loop
ii
ire
followup
studi
group
demonstr
hnrnp
induc
conform
chang
upon
bind
stem
loop
ii
ire
lead
enhanc
viral
protein
translat
hnrnp
also
link
regul
replic
virus
hepat
c
viru
human
cytomegaloviru
interact
immedi
earli
gene
protein
dengu
viru
human
papillomaviru
among
virus
far
upstream
element
bind
protein
describ
lin
colleagu
itaf
neg
regul
ire
depend
replic
followup
studi
group
show
induc
proteasom
autophagi
caspas
activ
mediat
cleavag
posit
regul
viral
protein
synthesi
anoth
nuclear
protein
also
demonstr
transloc
cytoplasm
infect
bind
viral
ire
recruit
ribosom
site
enhanc
viral
protein
synthesi
thu
act
posit
itaf
studi
zhang
cowork
describ
nuclear
factor
cellular
factor
srcassoci
protein
mitosi
posit
itaf
upon
transloc
cytoplasm
human
host
factorsvir
protein
studi
identifi
nuclear
factor
adenosineuridin
au
rich
element
rna
bind
factor
target
cleavag
viral
proteas
upon
transloc
cytoplasm
enhanc
stabil
ire
depend
viral
rna
product
similar
antivir
observ
made
polioviru
coxsackieviru
human
rhinoviru
rozov
colleagu
report
depend
cleavag
polioviru
rhinoviru
infect
enhanc
rna
replic
interestingli
replic
anoth
picornaviru
emcv
affect
messeng
rna
decay
protein
observ
enterovirus
suggest
varianc
restrict
mechan
nuclear
factor
investig
role
infect
lin
colleagu
show
reloc
cytoplasm
infect
bind
viral
ire
restrict
viral
rna
product
nuclear
factor
shown
effect
replic
picornavirus
point
possibl
global
role
viral
infect
offer
possibl
target
develop
antivir
enterovirus
host
factor
describ
involv
picornavir
translat
activ
includ
misshapen
nckrelat
kinas
mink
heterogen
nuclear
ribonucleoprotein
c
la
autoantigen
hepat
c
capindepend
translat
polypyrimidin
tractbind
protein
ptb
poli
rc
bind
protein
pcbp
ire
depend
translat
polioviru
doubl
strand
rna
bind
protein
act
neg
ire
regul
rhinoviru
well
ploy
rc
bind
protein
boost
polioviru
rhinoviru
ire
depend
translat
mode
action
enteroviru
ire
fulli
understood
seem
myriad
host
nuclear
factor
involv
capindepend
viral
replic
need
research
help
identifi
host
factor
involv
enterovir
ire
depend
rna
product
identifi
host
factor
bind
ire
enteroviru
capindepend
viral
translat
key
understand
viral
replic
cycl
neuron
cell
death
result
enterovir
infect
observ
case
hfmd
mechan
link
program
cell
death
long
common
belief
apoptosi
necrosi
major
player
program
cell
death
review
mechan
includ
pyroptosi
necroptosi
describ
play
role
complement
apoptosi
restrict
viral
infect
process
induc
pyroptosi
first
describ
salmonella
enterica
serovar
typhimurium
bacteria
elucid
use
speci
bacteria
escap
inflammasom
stimul
cell
death
review
pyroptosi
inflammatori
program
cell
death
link
cell
death
infect
neuron
cell
line
mediat
inflamm
link
pyroptosi
infect
upregul
well
downstream
stimul
gene
viral
infect
neuron
cell
line
sknsh
yogarajah
cowork
recent
identifi
radic
sadenosylmethionin
domain
contain
absent
melanoma
modul
infect
neuron
cell
consist
previou
find
research
group
upregul
result
reduc
viral
replic
result
studi
point
mechan
involv
neuron
complic
observ
fatal
case
infect
observ
infect
observ
postul
result
differenti
stimul
host
factor
viral
infect
viral
nontranls
region
involv
pyroptosi
viral
infect
report
virus
includ
encephalomyocard
viru
emcv
rhinoviru
adenovirus
virus
known
target
variou
host
cellular
factor
effect
effici
replic
sever
virus
shown
target
human
host
cell
cycl
arrest
cell
divis
therebi
avoid
competit
divid
cell
effici
genom
replic
dna
virus
shown
abil
enter
cell
cycl
phase
arrest
cycl
viral
replic
exampl
simian
viru
human
papillomaviru
viral
protein
interact
well
herp
simplex
viru
abil
block
cell
cycl
review
detail
flemington
colleagu
shown
usurp
cell
cycl
effici
viral
replic
process
infecti
bronchiti
viru
ibv
coronaviru
shown
li
colleagu
well
dove
cowork
induc
cell
cycl
arrest
g
phase
improv
viral
replic
influenza
viru
replic
shown
interact
cell
divis
factor
result
arrest
cell
cycl
divis
arrest
cell
cycl
phase
human
immunodefici
viral
protein
r
vpr
block
b
complex
stimul
coronavirus
sever
acut
respiratori
syndrom
mous
hepat
viru
mhv
abl
captur
cell
cycl
phase
effici
genom
replic
among
enterovirus
cell
cycl
arrest
report
recent
virus
target
cell
cycl
host
factor
help
virus
replic
within
cell
limit
competit
activ
divid
cell
complet
understand
virus
take
advantag
cellular
process
protein
establish
effici
infect
genom
replic
vital
develop
vaccin
antivir
therapi
virus
disrupt
cell
cycl
divis
phase
report
infect
therebi
block
entri
cell
phase
viral
rna
depend
rna
polymeras
nonstructur
protein
studi
show
mediat
cell
cycl
increas
transcript
cyclin
promot
proteasom
degrad
cyclin
eventu
phosphoryl
cyclin
depend
kinas
thu
regul
express
key
cyclin
regul
studi
also
show
anoth
picornaviru
coxsackieviru
infect
well
mediat
cell
cycl
divis
disrupt
phase
factor
control
cell
cycl
differenti
aurora
b
kinas
aurkb
cyclin
depend
kinas
identifi
wu
colleagu
restrict
factor
mediat
synchron
cell
divis
phase
thu
promot
viral
replic
cell
cycl
arrest
phase
inhibit
viral
replic
observ
contrari
cell
arrest
phase
promot
viral
replic
remark
cell
cycl
disrupt
phase
inhibit
viral
replic
virus
wang
colleagu
demonstr
first
time
disrupt
cell
divis
cycl
phase
viral
replic
nonstructur
protein
rnadepend
rna
polymeras
proteas
protein
virus
depend
host
cell
protein
process
effici
genom
replic
exploit
cell
cycl
process
highli
regul
process
enabl
virus
unfett
access
cell
cycl
factor
effici
viral
replic
futur
work
look
cell
cycl
stage
enterovirus
disrupt
cell
divis
cycl
enabl
better
antivir
therapi
design
develop
target
differ
virus
associ
hfmd
well
form
enterovir
infect
process
autophagi
link
format
doubl
membran
structur
act
replic
site
enterovirus
includ
polioviru
pv
format
membran
structur
depend
exploit
autophagi
process
enterovirus
pv
cvb
among
enterovirus
bc
viral
protein
involv
recent
studi
link
autophagi
regul
format
autophagosom
replic
organel
coxsackieviru
b
cvb
thu
show
enterovirus
target
autophagi
process
also
regul
effici
replic
genom
wong
colleagu
show
coxsackieviru
induc
autophagosom
format
without
lysosom
degrad
protein
clearli
highlight
role
autophagosom
format
replic
organel
enterovir
infect
followup
studi
zhai
colleagu
observ
format
autophagosom
infect
fibroblast
balbc
mice
thu
link
autophagi
pathogenesi
myocard
infect
shed
viru
infect
cell
link
robinson
colleagu
extracellular
microvesicl
autophagosom
marker
role
autophagom
releas
viru
infect
cell
later
valid
sin
cowork
studi
sin
colleagu
demonstr
abil
egress
cell
infect
cell
via
dynamin
relat
protein
initi
mitochondri
fragment
process
vital
mitochondri
base
autophagi
eliminationmitophagi
studi
believ
local
mitochondria
initi
viru
induc
mitophagi
eventu
escap
cell
autophagosomeboundmitochondrionviru
complex
role
mitophagosom
releas
viru
explain
possibl
altern
process
use
picornavirus
releas
infect
cell
infect
cell
thu
ensur
infect
cycl
sustain
disrupt
mitochondri
dynam
viru
induc
stimul
block
viru
induc
apoptosi
eventu
persist
viral
infect
also
observ
hcv
point
fact
differ
singl
strand
rna
virus
may
use
process
disrupt
mitochondri
traffic
eventu
apoptosi
viral
replic
mainten
viral
infect
cycl
enteroviru
induc
autophagi
report
vivo
vitro
protein
local
microtubuleassoci
protein
light
chain
receptor
mpr
result
format
amphisom
therebi
increas
viral
replic
bc
nonstructur
protein
recent
shown
trigger
format
autolysosom
human
rhabdomyosarcoma
cell
thu
enhanc
replic
studi
also
show
bc
protein
interact
nethylmaleimidesensit
factor
attach
receptor
snare
protein
synaptosom
associ
protein
microtubuleassoci
protein
light
chain
major
player
format
autolysosom
result
studi
consist
earlier
find
link
enteroviru
bc
nonstructur
protein
exploit
autophagi
process
support
enteroviru
viral
replic
corona
colleagu
show
enteroviru
abl
disrupt
autophagi
process
downstream
promot
viral
replic
eventu
egress
cell
thu
promot
viral
infect
within
cell
phenomena
link
viral
protein
interact
variou
regul
autophagi
process
effici
viral
replic
transmiss
review
anoth
pend
issu
enterovirus
abl
replic
insid
acid
autophagosom
evad
degrad
exit
cell
intact
howev
far
link
enterovirus
abil
divert
cargo
traffic
away
degrad
proteas
illustr
target
cleavag
snare
protein
key
regul
autophagosom
fusion
eventu
impair
establish
snare
complex
role
autophagi
regul
enteroviru
infect
also
studi
exampl
studi
delormeaxford
show
autophagi
regul
bactericidalpermeabilityincreas
protein
bpi
foldcontain
famili
b
member
act
host
limit
factor
coxsackieviru
b
viru
infect
studi
report
may
play
role
downregul
key
step
involv
autophagi
process
propos
help
format
membran
need
enterovirus
replic
studi
moroski
colleagu
link
anoth
protein
famili
bpifb
posit
regul
cvb
suggest
bpifb
famili
protein
may
divers
effect
regul
viral
infect
recent
studi
delormeaxford
cowork
identifi
exoribonucleas
neg
posttranscript
regul
autophagi
studi
also
show
maintain
process
autophagi
basal
level
thu
limit
replic
polioviru
coxsackieviru
b
recent
studi
velazquez
colleagu
demonstr
polioviru
gener
autophagosom
downstream
signal
pathway
cleav
cargo
traffick
may
neg
interfer
cargo
load
point
abil
picornavirus
finetun
interact
autophagi
machineri
effect
surviv
within
cell
target
autophagi
key
player
auxiliari
factor
report
number
picornavirus
viral
shown
cleav
sequestosom
known
intermediari
select
autophagi
degrad
ubiquitin
protein
studi
show
cleavag
result
impair
nfkb
signal
eventu
disrupt
select
autophagi
infect
cell
emerg
provir
strategi
establish
effici
infect
infect
subsequ
studi
mohamud
colleagu
demonstr
anoth
host
factor
calcium
bind
coiledcoil
domaincontain
protein
dot
protein
regul
viru
infect
target
autophagi
receptor
via
interact
viral
protein
studi
also
show
target
mitochondri
antivir
signal
protein
degrad
therebi
block
establish
antivir
state
within
infect
cell
effici
establish
infect
differ
strategi
use
virus
trigger
hijack
process
autophagi
recent
review
detail
zhang
cowork
autophagi
key
control
variou
cellular
process
includ
enhanc
innat
immun
signal
viral
infect
process
known
virophagi
abil
viru
infect
mitophagosom
releas
infect
cell
provid
import
mechan
viru
egress
infect
cell
enterovirus
shown
abil
interact
cellular
autophag
process
convent
known
degrad
mitochondri
traffic
upon
fusion
lysosom
enterovirus
evolv
way
evad
process
degrad
variou
autophagi
initi
factor
well
regul
host
cellular
process
link
nonlyt
exit
variou
enteroviru
infect
includ
polioviru
echoviru
virus
howev
block
initi
mitophagi
way
control
viral
infect
may
feasibl
given
observ
differ
studi
shown
disrupt
extracellular
microvesicl
emv
releas
replic
abil
viru
thu
process
provid
ideal
antivir
target
overview
human
host
cellprocess
npev
viral
protein
interact
highlight
tabl
much
achiev
develop
antivir
npev
infect
major
challeng
develop
antivir
alway
mutat
viral
genom
sever
compound
test
possibl
use
antivir
enterovirus
shown
tabl
much
success
achiev
drug
screen
done
vitro
littl
success
vivo
clinic
trial
screen
fda
approv
drug
repurpos
exist
drug
base
known
viralhuman
protein
interact
strategi
adopt
scientist
identifi
antivir
npev
exampl
li
colleagu
evalu
effect
ribavirin
known
antivir
rna
virus
possibl
repurpos
drug
studi
show
decreas
viru
yield
vitro
reduc
diseas
statu
death
advers
effect
associ
infect
vivo
highlight
possibl
role
antivir
compound
plant
metabolit
also
target
possibl
antivir
compound
enterovirus
exampl
quercetin
well
distribut
plant
flavonoid
shown
recent
inhibit
infect
inhibit
viru
attach
adsorpt
target
viral
proteas
antivir
efficaci
pyrazolo
pyrimidin
also
evalu
enterovirus
viru
infect
inhibit
infect
exact
mechan
establish
recent
andrographolid
report
suppress
replic
target
viral
matur
within
acidifi
endosom
world
health
organ
recommend
combin
therapi
also
evalu
possibl
antivir
develop
enterovirus
screen
fda
approv
drug
recogn
pirlindol
strong
inhibitor
natur
product
recent
gain
much
interest
drug
develop
studi
plant
secondari
metabolit
flavonoid
interest
drug
therapi
screen
viral
infect
given
freeli
avail
form
better
part
human
dietari
screen
plant
metabolit
possibl
use
antivir
therapi
report
review
zakaryan
colleagu
biolog
activ
well
chemistri
also
extens
review
flavonoid
antivir
abil
vitro
viral
infect
includ
isoquercitrin
zika
viru
infect
chikungunya
infect
apigenin
antivir
effect
number
virus
african
swine
fever
viru
asfv
hepat
c
viru
apigenin
also
shown
antivir
activ
viru
inhibit
viral
ire
depend
translat
recent
screen
flavonoid
librari
identifi
lead
antivir
compound
enterovirus
concert
effort
toward
identifi
antivir
enterovirus
viral
infect
need
followup
valid
anim
model
good
news
alreadi
identifi
compound
shown
cytotox
cell
thu
may
toxic
effect
anim
model
efficaci
identifi
compound
elucid
vitro
thu
need
studi
identifi
effect
vitro
littl
success
achiev
term
antivir
therapi
enterovirus
given
drug
discoveri
process
expens
timeconsum
ventur
research
reli
fda
approv
drug
drug
alreadi
use
possibl
repurpos
much
success
drug
therapi
record
viral
infect
due
high
mutat
rate
observ
viral
replic
combin
therapi
drug
differ
mode
action
target
differ
stage
viral
infect
would
altern
target
differ
stage
enterovir
infect
cycl
achiev
complet
map
human
host
factor
hijack
virus
infect
thu
need
continu
elucid
molecular
mechan
alreadi
postul
viral
target
well
identifi
underli
factor
process
vaccin
shown
much
success
viral
infect
success
stori
vaccin
polioviru
infect
world
picornaviru
point
need
continu
studi
toward
identifi
vaccin
candid
enterovir
infect
outbreak
enterovirus
record
differ
part
world
check
might
potenti
threat
global
health
soon
near
erad
polioviru
infect
emerg
outbreak
enterovir
infect
differ
part
world
point
need
map
host
factor
involv
infect
paradigm
given
virus
need
host
factor
everi
step
infect
attach
entri
replic
virion
assembl
eventu
entri
need
elucid
host
factor
involv
improv
understand
molecular
dynam
enterovir
infect
big
boost
toward
long
overdu
antivir
vaccin
develop
epidemiolog
import
virus
much
elucid
format
npev
replic
complex
format
exist
mechan
wholli
explain
process
step
involv
import
process
viral
replic
nuclear
host
factor
involv
enterovir
replic
also
need
fulli
describ
vital
step
maintain
viral
replic
eventu
life
cycl
viral
entri
studi
need
carri
known
receptor
viral
entri
requir
fulli
explain
myriad
diseas
featur
observ
viral
infect
role
cellular
process
autophagi
apoptosi
necroptosi
pyroptosi
well
posttransl
modif
enterovir
infect
also
need
fulli
elucid
specif
import
explain
littleknown
stage
viral
infect
nonlyt
egress
continu
viral
cycl
within
host
pauciti
inform
infect
dynam
virus
call
concert
effort
elucid
viralhuman
cell
interact
still
lot
investig
fill
gap
exist
life
cycl
nonpolio
enterovirus
new
case
emerg
differ
part
world
matter
time
global
outbreak
nonpolioviru
enterovir
infect
differ
part
world
also
urgent
need
studi
especi
field
vaccin
develop
well
antivir
therapi
enterovirus
